Published in J Virol on May 01, 2006
The emergence of porcine circovirus 2b genotype (PCV-2b) in swine in Canada. Can Vet J (2007) 1.42
The emergence of a new strain of porcine circovirus-2 in Ontario and Quebec swine and its association with severe porcine circovirus associated disease--2004-2006. Can J Vet Res (2008) 1.39
Insights into the evolutionary history of an emerging livestock pathogen: porcine circovirus 2. J Virol (2009) 1.19
The ORF3 protein of porcine circovirus type 2 interacts with porcine ubiquitin E3 ligase Pirh2 and facilitates p53 expression in viral infection. J Virol (2007) 0.97
Porcine circovirus type 2 induces autophagy via the AMPK/ERK/TSC2/mTOR signaling pathway in PK-15 cells. J Virol (2012) 0.96
Identification and functional analysis of the novel ORF4 protein encoded by porcine circovirus type 2. J Virol (2012) 0.95
Porcine circovirus type 2 in China: an update on and insights to its prevalence and control. Virol J (2014) 0.91
JNK and p38 mitogen-activated protein kinase pathways contribute to porcine circovirus type 2 infection. J Virol (2009) 0.90
Immunization of mice by hollow mesoporous silica nanoparticles as carriers of porcine circovirus type 2 ORF2 protein. Virol J (2012) 0.88
Cytotoxicity of ORF3 proteins from a nonpathogenic and a pathogenic porcine circovirus. J Virol (2010) 0.88
Patterns and influencing factor of synonymous codon usage in porcine circovirus. Virol J (2012) 0.87
Porcine Circovirus 2 Deploys PERK Pathway and GRP78 for Its Enhanced Replication in PK-15 Cells. Viruses (2016) 0.80
Recognition of the different structural forms of the capsid protein determines the outcome following infection with porcine circovirus type 2. J Virol (2012) 0.80
Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway during porcine circovirus type 2 infection facilitates cell survival and viral replication. J Virol (2012) 0.80
Functional exchangeability of the nuclear localization signal (NLS) of capsid protein between PCV1 and PCV2 in vitro: Implications for the role of NLS in viral replication. Virol J (2011) 0.80
Pigs naturally exposed to porcine circovirus type 2 (PCV2) generate antibody responses capable to neutralise PCV2 isolates of different genotypes and geographic origins. Vet Res (2014) 0.77
Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein Promotes Protective Immune Responses in Mice. PLoS One (2015) 0.76
Involvement of miR-15a in G0/G1 Phase Cell Cycle Arrest Induced by Porcine Circovirus Type 2 Replication. Sci Rep (2016) 0.76
In vivo characterization of chimeric PCV DNA clones containing heterogeneous capsid protein nuclear localization signals (NLS). Virol J (2013) 0.75
In Vitro Coinfection and Replication of Classical Swine Fever Virus and Porcine Circovirus Type 2 in PK15 Cells. PLoS One (2015) 0.75
The Porcine Circovirus Type 2 Nonstructural Protein ORF3 Induces Apoptosis in Porcine Peripheral Blood Mononuclear Cells. Open Virol J (2011) 0.75
Development of real-time PCR assay for detection of porcine circovirus-like virus P1 in domestic pigs in China. BMC Vet Res (2015) 0.75
Peptides mimicking viral proteins of porcine circovirus type 2 were profiled by the spectrum of mouse anti-PCV2 antibodies. BMC Immunol (2017) 0.75
Porcine circovirus type 2 capsid protein induces unfolded protein response with subsequent activation of apoptosis. J Zhejiang Univ Sci B (2017) 0.75
Enhancing mucosal immunity in mice by recombinant adenovirus expressing major epitopes of porcine circovirus-2 capsid protein delivered with cytosine-phosphate-guanosine oligodeoxynucleotides. J Vet Sci (2014) 0.75
p53 signaling modulation of cell cycle arrest and viral replication in porcine circovirus type 2 infection cells. Vet Res (2016) 0.75
Analysis of putative ORF3 gene within porcine circovirus type 2. Hybridoma (Larchmt) (2012) 0.75
Global Status of Porcine circovirus Type 2 and Its Associated Diseases in Sub-Saharan Africa. Adv Virol (2017) 0.75
Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 2. PLoS One (2017) 0.75
Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science (1999) 21.24
Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med (1999) 14.30
Viruses and apoptosis. Annu Rev Microbiol (1999) 4.24
Studies on epidemiology and pathogenicity of porcine circovirus. Arch Virol (1986) 3.58
Porcine circoviruses: a review. J Vet Diagn Invest (2000) 3.53
Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome. Can Vet J (1998) 3.19
Isolation of porcine circovirus-like viruses from pigs with a wasting disease in the USA and Europe. J Vet Diagn Invest (1998) 3.18
Virus taxonomy at the XIth International Congress of Virology, Sydney, Australia, 1999. Arch Virol (1999) 2.73
Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. J Gen Virol (2000) 2.45
Pathogenesis of porcine circovirus; experimental infections of colostrum deprived piglets and examination of pig foetal material. Vet Microbiol (1995) 2.36
Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques. J Virol (2005) 2.01
Reproduction of lesions of postweaning multisystemic wasting syndrome in gnotobiotic piglets. J Vet Diagn Invest (1999) 1.98
Characterization of a previously unidentified viral protein in porcine circovirus type 2-infected cells and its role in virus-induced apoptosis. J Virol (2005) 1.92
Identification of a protein essential for replication of porcine circovirus. J Gen Virol (1998) 1.92
A single chicken anemia virus protein induces apoptosis. J Virol (1994) 1.91
Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus. J Comp Pathol (1999) 1.88
Replication of porcine circovirus: induction by glucosamine and cell cycle dependence. Arch Virol (1987) 1.81
Postweaning multisystemic wasting syndrome (PMWS) in pigs. A review. Vet Q (2002) 1.68
Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. J Virol (2005) 1.68
Transcriptional analysis of porcine circovirus type 2. Virology (2003) 1.63
Presence of antibodies reacting with porcine circovirus in sera of humans, mice, and cattle. Arch Virol (1995) 1.58
Characterisation of PCV-2 isolates from Spain, Germany and France. Virus Res (2000) 1.55
Reproduction of lesions of postweaning multisystemic wasting syndrome by infection of conventional pigs with porcine circovirus type 2 alone or in combination with porcine parvovirus. J Comp Pathol (2000) 1.45
Evidence for circovirus in cattle with respiratory disease and from aborted bovine fetuses. Can Vet J (1999) 1.43
Inhibition of translation and induction of apoptosis by Bunyaviral nonstructural proteins bearing sequence similarity to reaper. Mol Biol Cell (2003) 1.32
Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs. J Virol (2003) 1.32
Reproduction of postweaning multisystemic wasting syndrome (PMWS) in immunostimulated and non-immunostimulated 3-week-old piglets experimentally infected with porcine circovirus type 2 (PCV2). Vet Microbiol (2002) 1.32
Association of lymphopenia with porcine circovirus type 2 induced postweaning multisystemic wasting syndrome (PMWS). Vet Immunol Immunopathol (2003) 1.23
Pathogenesis of postweaning multisystemic wasting syndrome caused by Porcine circovirus 2: An immune riddle. Arch Virol (2004) 1.15
Evidence of circovirus infection in British pigs. Vet Rec (1994) 1.15
Porcine postweaning multisystemic wasting syndrome in Korean pig: detection of porcine circovirus 2 infection by immunohistochemistry and polymerase chain reaction. J Vet Diagn Invest (2000) 1.15
Genetic characterization and phylogenetic analysis of porcine circovirus type 2 (PCV2) strains from cases presenting various clinical conditions. Virus Res (2002) 1.15
Detection of porcine circovirus from lesions of a pig with wasting disease in Japan. J Vet Med Sci (1999) 1.14
Generation of a mutant infectious bursal disease virus that does not cause bursal lesions. J Virol (1998) 1.14
Circovirus-like viral associated disease in weaned pigs in Indiana. Vet Pathol (1998) 1.14
Experimental inoculation of porcine circoviruses type 1 (PCV1) and type 2 (PCV2) in rabbits and mice. Vet Res (2002) 1.12
Changes in peripheral blood leukocyte populations in pigs with natural postweaning multisystemic wasting syndrome (PMWS). Vet Immunol Immunopathol (2001) 1.12
Two amino acid mutations in the capsid protein of type 2 porcine circovirus (PCV2) enhanced PCV2 replication in vitro and attenuated the virus in vivo. J Virol (2004) 1.10
A review of evidence for immunosuppression due to porcine reproductive and respiratory syndrome virus. Vet Res (2000) 1.08
Viral replication and lesions in BALB/c mice experimentally inoculated with porcine circovirus isolated from a pig with postweaning multisystemic wasting disease. Vet Pathol (2001) 1.03
Induction of apoptosis in vitro by the 17-kDa nonstructural protein of infectious bursal disease virus: possible role in viral pathogenesis. Virology (2001) 1.02
Changes in CD4(+), CD8(+), CD4(+) CD8(+), and immunoglobulin M-positive peripheral blood mononuclear cells of postweaning multisystemic wasting syndrome-affected pigs and age-matched uninfected wasted and healthy pigs correlate with lesions and porcine circovirus type 2 load in lymphoid tissues. Clin Diagn Lab Immunol (2002) 0.99
Isolation and characterization of porcine circovirus type 2 from pigs showing signs of post-weaning multisystemic wasting syndrome in The Netherlands. Vet Q (2000) 0.95
Development of an ELISA based on the baculovirus-expressed capsid protein of porcine circovirus type 2 as antigen. J Vet Med Sci (2004) 0.90
Apoptosis and loss of virus-specific CD8+ T-cell memory. Curr Opin Immunol (2004) 0.87
Inhibition of porcine circovirus type 2 replication in mice by RNA interference. Virology (2006) 0.79
Characterization of a previously unidentified viral protein in porcine circovirus type 2-infected cells and its role in virus-induced apoptosis. J Virol (2005) 1.92
Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection. J Virol (2008) 1.62
Betanodavirus B2 is an RNA interference antagonist that facilitates intracellular viral RNA accumulation. J Virol (2006) 1.30
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Virology (2008) 1.25
RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice. J Virol (2004) 1.16
Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages. J Virol (2010) 1.16
Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus. J Clin Microbiol (2004) 1.13
Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS One (2009) 1.12
GM-CSF and IL-4 stimulate antibody responses in humanized mice by promoting T, B, and dendritic cell maturation. J Immunol (2012) 1.11
Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants. PLoS One (2009) 1.10
Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody. Clin Vaccine Immunol (2007) 1.09
RING-H2 protein WSSV249 from white spot syndrome virus sequesters a shrimp ubiquitin-conjugating enzyme, PvUbc, for viral pathogenesis. J Virol (2005) 1.09
Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection. J Virol (2010) 1.08
Identification of white spot syndrome virus latency-related genes in specific-pathogen-free shrimps by use of a microarray. J Virol (2003) 1.08
Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome. Virology (2005) 1.03
Baculovirus as vaccine vectors. Curr Gene Ther (2010) 1.03
Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection. PLoS One (2012) 1.02
Expression of hemagglutinin protein from the avian influenza virus H5N1 in a baculovirus/insect cell system significantly enhanced by suspension culture. BMC Microbiol (2006) 1.01
White spot syndrome virus open reading frame 222 encodes a viral E3 ligase and mediates degradation of a host tumor suppressor via ubiquitination. J Virol (2006) 1.01
Identification and characterization of a new E3 ubiquitin ligase in white spot syndrome virus involved in virus latency. Virol J (2008) 0.99
Recovery of infectious rabbit hemorrhagic disease virus from rabbits after direct inoculation with in vitro-transcribed RNA. J Virol (2006) 0.99
Development of an antigen-capture ELISA for detection of H7 subtype avian influenza from experimentally infected chickens. J Virol Methods (2007) 0.97
The ORF3 protein of porcine circovirus type 2 interacts with porcine ubiquitin E3 ligase Pirh2 and facilitates p53 expression in viral infection. J Virol (2007) 0.97
Characterization of ORF89--a latency-related gene of white spot syndrome virus. Virology (2004) 0.96
Development of a Western blot assay for detection of antibodies against coronavirus causing severe acute respiratory syndrome. Clin Diagn Lab Immunol (2004) 0.96
Rapid detection of H5N1 subtype influenza viruses by antigen capture enzyme-linked immunosorbent assay using H5- and N1-specific monoclonal antibodies. Clin Vaccine Immunol (2009) 0.96
Retracted Baculovirus surface-displayed hemagglutinin of H5N1 influenza virus sustains its authentic cleavage, hemagglutination activity, and antigenicity. Biochem Biophys Res Commun (2007) 0.95
Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA. J Virol Methods (2005) 0.95
Neuroendocrine-immune interactions in fish: a role for interleukin-1. Vet Immunol Immunopathol (2002) 0.94
Immunohistochemical detection of Influenza virus infection in formalin-fixed tissues with anti-H5 monoclonal antibody recognizing FFWTILKP. J Virol Methods (2008) 0.93
Identification of a novel shrimp protein phosphatase and its association with latency-related ORF427 of white spot syndrome virus. FEBS Lett (2004) 0.93
Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice. PLoS One (2011) 0.93
Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice. J Virol (2014) 0.93
WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccine. BMC Microbiol (2008) 0.92
Baculovirus vector as a delivery vehicle for influenza vaccines. Expert Rev Vaccines (2009) 0.92
Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge. Vaccine (2013) 0.92
Membrane association of greasy grouper nervous necrosis virus protein A and characterization of its mitochondrial localization targeting signal. J Virol (2004) 0.91
Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza. Antivir Ther (2009) 0.91
Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein. Virol J (2012) 0.91
Dissection of double-stranded RNA binding protein B2 from betanodavirus. J Virol (2007) 0.90
Identification of nucleolus localization signal of betanodavirus GGNNV protein alpha. Virology (2003) 0.90
Sequestration and protection of double-stranded RNA by the betanodavirus b2 protein. J Virol (2006) 0.90
Localization of VP28 on the baculovirus envelope and its immunogenicity against white spot syndrome virus in Penaeus monodon. Virology (2009) 0.89
Induction of caspase-dependent apoptosis by betanodaviruses GGNNV and demonstration of protein alpha as an apoptosis inducer. Virology (2003) 0.88
Baculovirus-mediated promoter assay and transcriptional analysis of white spot syndrome virus orf427 gene. Virol J (2005) 0.88
Effective intranasal therapeutics and prophylactics with monoclonal antibody against lethal infection of H7N7 influenza virus. Antiviral Res (2013) 0.86
Attenuation of porcine circovirus 2 in SPF piglets by abrogation of ORF3 function. Virology (2008) 0.86
ORF3 of porcine circovirus 2 enhances the in vitro and in vivo spread of the of the virus. Virology (2010) 0.86
Complementary monoclonal antibody-based dot ELISA for universal detection of H5 avian influenza virus. BMC Microbiol (2010) 0.86
Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoV. J Immunol Methods (2004) 0.85
Natural compounds inhibiting the replication of Porcine reproductive and respiratory syndrome virus. Antiviral Res (2012) 0.85
A novel peptide ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS One (2011) 0.85
Porcine circovirus type 2 induces the activation of nuclear factor kappa B by IkappaBalpha degradation. Virology (2008) 0.85
Vaccination of ducks with recombinant outer membrane protein (OmpA) and a 41 kDa partial protein (P45N') of Riemerella anatipestifer. Vet Microbiol (2002) 0.85
Viral ubiquitin ligase WSSV222 is required for efficient white spot syndrome virus replication in shrimp. J Gen Virol (2009) 0.84
Novel immunofluorescence assay using recombinant nucleocapsid-spike fusion protein as antigen to detect antibodies against severe acute respiratory syndrome coronavirus. Clin Diagn Lab Immunol (2005) 0.84
Oral vaccination of baculovirus-expressed VP28 displays enhanced protection against White Spot Syndrome Virus in Penaeus monodon. PLoS One (2011) 0.83
RNA polymerase I-driven reverse genetics system for enterovirus 71 and its implications for vaccine production. Virol J (2012) 0.83
Avian encephalomyelitis virus nonstructural protein 2C induces apoptosis by activating cytochrome c/caspase-9 pathway. Virology (2004) 0.82
Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1. Antiviral Res (2012) 0.82
Monoclonal Antibody Targeting Neutralizing Epitope on H5N1 Influenza Virus of Clade 1 and 0 for Specific H5 Quantification. Influenza Res Treat (2013) 0.82
Avian encephalomyelitis virus induces apoptosis via major structural protein VP3. Virology (2002) 0.81
Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus. PLoS One (2013) 0.81
Porcine circovirus type 2 ORF3 protein competes with p53 in binding to Pirh2 and mediates the deregulation of p53 homeostasis. Virology (2009) 0.81
Identification of novel attenuated Salmonella Enteritidis mutants. FEMS Immunol Med Microbiol (2008) 0.81
Immune responses to baculovirus-displayed enterovirus 71 VP1 antigen. Expert Rev Vaccines (2013) 0.80
Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice. Antiviral Res (2010) 0.80
Deletion of the aceE gene (encoding a component of pyruvate dehydrogenase) attenuates Salmonella enterica serovar Enteritidis. FEMS Immunol Med Microbiol (2011) 0.80
Development of miniaturized competitive immunoassays on a protein chip as a screening tool for drugs. Clin Chem (2004) 0.80
Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains. PLoS One (2013) 0.79
Inhibition of porcine circovirus type 2 replication in mice by RNA interference. Virology (2006) 0.79
Evaluation of a Subunit H5 Vaccine and an Inactivated H5N2 Avian Influenza Marker Vaccine in Ducks Challenged with Vietnamese H5N1 Highly Pathogenic Avian Influenza Virus. Influenza Res Treat (2010) 0.79
A novel baculovirus vector shows efficient gene delivery of modified porcine reproductive and respiratory syndrome virus antigens and elicits specific immune response. Vaccine (2013) 0.79
Enhanced replication of porcine circovirus type 2 (PCV2) in a homogeneous subpopulation of PK15 cell line. Virology (2007) 0.79
Development of an ELISA using a recombinant 41 kDa partial protein (P45N') for the detection of Riemerella anatipestifer infections in ducks. Vet Microbiol (2002) 0.79
Membrane-association properties of avian encephalomyelitis virus protein 3A. Virology (2004) 0.78
The VP1 protein of avian encephalomyelitis virus is a major host-protective immunogen that serves as diagnostic potential. J Virol Methods (2008) 0.78
Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice. Virus Res (2012) 0.78
Sf-PHB2, a new transcription factor, drives WSSV Ie1 gene expression via a 12-bp DNA element. Virol J (2012) 0.78
Development of dual-function ELISA for effective antigen and antibody detection against H7 avian influenza virus. BMC Microbiol (2013) 0.78
Characterization of a novel monoclonal antibody reactive against the N-terminal region of Enterovirus 71 VP1 capsid protein. J Virol Methods (2012) 0.78
Identification and characterization of a monoclonal antibody recognizing the linear epitope RVADVI on VP1 protein of enterovirus 71. J Med Virol (2012) 0.77
Suppression of porcine arterivirus replication by baculovirus-delivered shRNA targeting nucleoprotein. Biochem Biophys Res Commun (2006) 0.77
Production of a monoclonal antibody specific for the major outer membrane protein of Campylobacter jejuni and characterization of the epitope. Appl Environ Microbiol (2007) 0.77
Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic H1N1 Influenza A virus induces protective immunity in mice. Clin Vaccine Immunol (2011) 0.77
Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice. PLoS One (2013) 0.76
Characterization of a monoclonal antibody against the 3D polymerase of enterovirus 71 and its use for the detection of human enterovirus A infection. J Virol Methods (2011) 0.76
Characterization and epitope mapping of monoclonal antibodies recognizing N-terminus of Rep of porcine circovirus type 2. J Virol Methods (2010) 0.76
Antigenic and molecular characterization of recent infectious bursal disease virus isolates in China. Virus Genes (2002) 0.75